MAX
Spero Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-1.86 | 33.29 | -105.59% | -2.9 | -35.89% |
| P/S |
|
2.01 | 129.32 | -98.44% |
|
|
| P/BV |
|
1.2 | 254.5 | -99.53% |
|
|
| P/FCF |
|
-5.44 | -175.09 | -96.89% |
|
|
| Ev/Ebitda |
|
-0.089 | -27.64 | -99.68% |
|
|
| Ev/S |
|
0.24 | 535.9 | -99.96% |
|
|
| Ev/FCF |
|
-0.28 | -282.58 | -99.9% |
|
|
| E/P |
|
-0.54 | 0.022 | -2558.3% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-267.78 | -366.96 | -27.03% | -149.49 | +79.12% |
| ROE |
|
-89.62 | 104.24 | -185.97% |
|
|
| ROA |
|
-46.81 | -2.25 | 1978.47% |
|
|
| ROIC |
|
-101.05 | 1.17 | -8707.74% |
|
|
| ROS |
|
-250.28 | -291.95 | -14.27% |
|
|
| ROCE |
|
-159.06 | 3.45 | -4704.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0586 | 1.1 | -105.35% | -0.0259 | +126.02% |
| Nеt Debt/Ebitda |
|
0.66 | 1.17 | -43.39% |
|
|
| Debt/Ratio |
|
0.0389 | 0.19 | -79.83% |
|
|
| Debt/Equity |
|
1.4 | 1.62 | -13.7% |
|
|
| Debt/Net Income |
|
-0.0627 | -1.32 | -95.25% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.54 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 2.43 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.49 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.01 | -100% |
|
|
| Difference from average difference in sector |
|
-0.54 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
415.88 | -54.61 | -861.55% | ||
| Growth impulse Ebitda in 5 years |
|
-8.37 | -92 | -90.9% | ||
| Growth impulse Net Income in 5 years |
|
-10.6 | -77.77 | -86.37% | ||
| Growth impulse FCF in 5 years |
|
-72.74 | -91.82 | -20.78% | ||
| Growth impulse EPS in 5 years |
|
-63.01 | -75.92 | -17% |
IP Score
3.41/10
